Literature DB >> 9087827

Therapeutic ERCP in outpatients.

T C Tham1, J Vandervoort, R C Wong, D R Lichtenstein, J Van Dam, F Ruymann, F Farraye, D L Carr-Locke.   

Abstract

BACKGROUND: We evaluated the safety of outpatient therapeutic ERCP since most complications are apparent within a few hours.
METHODS: We reviewed 190 patients undergoing planned outpatient therapeutic ERCP from a cohort of 409 consecutive therapeutic ERCP procedures. Patients were selected for outpatient therapeutic ERCP based on relative good health and overnight accommodation near our institution.
RESULTS: Outpatient therapeutic ERCPs included plastic biliary stent insertion (n = 71), biliary sphincterotomy (45), pancreatic stent insertion (28), Wallstent insertion (19), biliary balloon or catheter dilation (10), pancreatic balloon or catheter dilation (8), biliary stone extraction with prior sphincterotomy (7), pancreatic sphincterotomy (5), and duodenal ampullectomy (1). Admission was necessary in 31 (16%) because of complications in 22 (11.6%) and observation of post-ERCP symptoms in 9. Twenty-six (13%) of these patients were admitted directly from the endoscopy unit recovery room and 5 (3%) from home after a median interval of 24 hours following discharge (range 5 to 48 hours). Reasons for admission were pancreatitis in 17, hemorrhage in 3, cholangitis in 3, endoscopic but not clinical hemorrhage in 4, pain in 4, and vomiting in 1. Of the patients who were admitted from home, 3 had pancreatitis (following sphincterotomy in 1, pancreatic stenting in 1, pancreatic balloon dilation in 1) and 2 had hemorrhage (postsphincterotomy in 1 and ampullectomy in 1). In comparison, of the 219 consecutive inpatients undergoing therapeutic ERCP, 28 (13%) developed complications with 1 (0.4%) death.
CONCLUSIONS: A policy of selective outpatient therapeutic ERCP, with admission reserved for those with established or suspected complication, appears to be safe and reduces health care costs.

Entities:  

Mesh:

Year:  1997        PMID: 9087827     DOI: 10.1016/s0016-5107(97)70263-3

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  5 in total

1.  Development and Validation of a Prediction Model for Admission After Endoscopic Retrograde Cholangiopancreatography.

Authors:  Gregory A Coté; Sheryl Lynch; Jeffery J Easler; Alyson Keen; Patricia A Vassell; Stuart Sherman; Siu Hui; Huiping Xu
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-27       Impact factor: 11.382

2.  Trends in the Use of Endoscopic Retrograde Cholangiopancreatography for the Management of Chronic Pancreatitis in the United States.

Authors:  Clancy J Clark; Nora F Fino; Norman Clark; Armando Rosales; Girsh Mishra; Rishi Pawa
Journal:  J Clin Gastroenterol       Date:  2016 May-Jun       Impact factor: 3.062

3.  Is outpatient ERCP suitable, feasible, and safe? The experience of a Spanish community hospital.

Authors:  Luís Rábago; Ivan Guerra; Marta Moran; Elvira Quintanilla; David Collado; Inmaculada Chico; Ana Olivares; Jose Luis Castro; Francisco Gea
Journal:  Surg Endosc       Date:  2010-01-01       Impact factor: 4.584

4.  Therapeutic Endoscopy Can Be Performed Safely in an Ambulatory Surgical Center: A Multicenter, Prospective Study.

Authors:  Shaffer R S Mok; Henry C Ho; John P Gaughan; Adam B Elfant
Journal:  Diagn Ther Endosc       Date:  2016-10-20

5.  Placement of lumen-apposing metal stents to drain pseudocysts and walled-off pancreatic necrosis can be safely performed on an outpatient basis: A multicenter study.

Authors:  Douglas G Adler; Janak Shah; Jose Nieto; Kenneth Binmoeller; Yasser Bhat; Linda Jo Taylor; Ali A Siddiqui
Journal:  Endosc Ultrasound       Date:  2019 Jan-Feb       Impact factor: 5.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.